Skip to main navigation Skip to search Skip to main content

Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

  • Rontgene Solante*
  • , Carlos Alvarez-Moreno
  • , Erlina Burhan
  • , Suwat Chariyalertsak
  • , Nan Chang Chiu
  • , Sunate Chuenkitmongkol
  • , Dung Do-Van
  • , Kao Pin Hwang
  • , Sasisopin Kiertiburanakul
  • , Ping Ing Lee
  • , Rommel Crisenio Lobo
  • , Alejandro Macias
  • , Cao Huu Nghia
  • , Anna Ong-Lim
  • , Javier Ortiz Ibarra
  • , Rosana Richtmann
  • , Alfonso J. Rodriguez-Morales
  • , Marco Aurélio P. Safadi
  • , Hindra Irawan Satari
  • *Corresponding author for this work
  • San Lazaro Hospital
  • Universidad Nacional de Colombia
  • University of Indonesia
  • Chiang Mai University
  • Mackay Memorial Hospital Taiwan
  • National Vaccine Institute
  • University of Medicine and Pharmacy at Ho Chi Minh City
  • China Medical University Children Hospital
  • Mahidol University
  • National Taiwan University
  • Philippine Children’s Medical Center
  • Universidad de Guanajuato
  • Pasteur Institute in Ho Chi Minh City
  • University of the Philippines
  • Hospital Materno Perinatal Monica Pretelini Sáez
  • Instituto de Infectologia Emílio Ribas
  • Fundación Universitaria Autónoma de las Américas
  • Universidad Científica del Sur
  • Santa Casa de Sao Paulo School of Medical Sciences

Research output: Contribution to journalJournal Letter peer-review

7 Scopus citations
Original languageEnglish
Pages (from-to)1355-1357
Number of pages3
JournalExpert Review of Vaccines
Volume21
Issue number9
DOIs
StatePublished - 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 4th dose
  • AZD1222
  • BNT162b2
  • COVID-19
  • Southeast Asia
  • Thailand
  • booster
  • vaccine effectiveness

Cite this